locator iconlocator icon
All Labs
 
add to cart

CA15.3

1100
4.2
NABL, ISO
ADD TO CART

What is CA15.3?

This assay is useful for predicting early recurrence in women treated for Carcinoma Breast. It is specially useful for serial testing in women with prior Stage II / III breast cancer who are clinically free of disease.

Preparation for CA15.3

  • No special preparation required

Sample Type for CA15.3

The sample type collected for CA15.3 is: Blood

Provided By

NABL

ISO

General Diagnostics Pvt Ltd is a medical technology company and provider of high-end Preventive Screening and Diagnostic tests with a special focus on metabolomics. General Diagnostics Pvt Ltd is also a Technology Solution Provider to laboratories world-wide offering services based on high end chromatographic instruments. Since its inception about a decade ago, General Diagnostics Pvt Ltd has been continually evolving, transforming and thriving in this ever changing field through its innovations, operational efficiency, and creation of breakthrough solutions. General Diagnostics Pvt Ltd has to its credit the world's most comprehensive genetic metabolic screening test, in addition to several other preventive tests which help address health conditions like diabetes, weight problems, food intolerances, allergies and dysbiosis.

Available at Other Labs

VIEW ALL